SCHEMBL25622693

SCHEMBL25622693

CC(C)C1CCCC(C)N1I

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.34
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13960106 0.80
SCHEMBL14409888 0.80
SCHEMBL17791237 0.80
SCHEMBL25019739 0.76 MGLL (0.37) MGLLACHE
SCHEMBL20192472 0.75
SCHEMBL18364683 0.73 MGLL (0.34) MGLLACHE
SCHEMBL19067245 0.70 MGLL (0.32) MGLLACHE
SCHEMBL1651455 0.69 MAPK1 (0.33)
SCHEMBL12071469 0.68
SCHEMBL17791238 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4194451-A1 COMPLEMENT FACTOR B INHIBITOR, AND PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF Shanghai Meiyue Biotech Development Co., Ltd. (CN) 2023-06-14 EP disclosed